CURRAX PHARMACEUTICALS LLC

Lobbying client · Tennessee · filed 2025 to 2026

Specialty pharmaceutical business

$310,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (56944), not by name.

Firms hired 1

DLA PIPER LLP (US) $310,000 6 filings

Bills named in these filings 2

HR 4231
Treat and Reduce Obesity Act of 2025

4 filings
S 1973
Treat and Reduce Obesity Act of 2025

4 filings

Reported by year 2 years

2026 $100,000 2 filings
2025 $210,000 4 filings

Issues lobbied 1

Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

HOUSE OF REPRESENTATIVES 6
SENATE 6
Centers For Medicare and Medicaid Services (CMS) 4
Executive Office of the President (EOP) 4
Health & Human Services, Dept of (HHS) 4

Recent filings 6 total

Q2

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026

View → Q1

DLA PIPER LLP (US)

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 income · posted Apr 20, 2026

View → Q4

DLA PIPER LLP (US)

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 income · posted Jan 20, 2026

View → Q3

DLA PIPER LLP (US)

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $50,000 income · posted Oct 20, 2025

View → Q2

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $50,000 income · posted Jul 21, 2025

View → Q1

DLA PIPER LLP (US)

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $60,000 income · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.